Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,610
Closed -$266K 263
2018
Q3
$266K Buy
6,610
+662
+11% +$26.4K 0.04% 216
2018
Q2
$228K Sell
5,948
-502
-8% -$18.5K 0.03% 227
2018
Q1
$221K Hold
6,450
0.03% 238
2017
Q4
$212K Sell
6,450
-214
-3% -$7.38K 0.03% 247
2017
Q3
$223K Sell
6,664
-7
-0.1% -$241 0.03% 241
2017
Q2
$237K Sell
6,671
-146
-2% -$4.93K 0.03% 237
2017
Q1
$209K Buy
+6,817
New +$210K 0.03% 243

Other funds holding QGEN

CIBC Bank USA's QGEN Position: Q4 2018 in Review

CIBC Bank USA sold out of Qiagen (QGEN) in Q4 2018, closing a stake of 6,610 shares — an estimated $266K sold.

CIBC Bank USA first reported a position in QGEN in Q1 2017 and held it in 7 quarters. The position peaked at $266K in Q3 2018. 251 funds tracked by Wall St. Rank hold QGEN as of Q4 2018.

  • CIBC Bank USA reported no remaining Qiagen position as of Q4 2018 after selling out during the quarter.
  • CIBC Bank USA sold 6,610 Qiagen shares in Q4 2018, an estimated $266K.
  • CIBC Bank USA first reported a position in Qiagen in Q1 2017 and held it in 7 quarters.
  • CIBC Bank USA's Qiagen position peaked at $266K in Q3 2018.
  • 251 funds tracked by Wall St. Rank held Qiagen as of Q4 2018.

Based on CIBC Bank USA's 13F filing for Q4 2018, filed 5 Feb 2019.